№ lp_1_23535
File format: docx
Character count: 22646
File size: 191 KB
This document outlines safety procedures for handling hydrofluoric acid in laboratory environments, focusing on hazard identification, emergency response, and proper handling techniques.
Year:
2023
Region / City:
United States
Subject:
Chemical Safety
Document Type:
Standard Operating Procedure (SOP)
Organization / Institution:
WSU
Author:
Not specified
Target Audience:
Laboratory staff, researchers
Effective Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Subject:
Chemical Safety, Laboratory Procedures
Document Type:
Standard Operating Procedure (SOP)
Target Audience:
Laboratory Personnel
Year:
2026
Region / City:
Gainesville, FL
Topic:
Chemical Safety
Document Type:
Safety Procedure
Organization / Institution:
University of Florida
Author:
Environmental Health & Safety (EH&S)
Target Audience:
Laboratory Personnel
Effective Period:
Indefinite
Approval Date:
2026-02-07
Review Date:
Every 2 years
Revision Date:
N/A
Description:
A standard operating procedure detailing safety precautions, training requirements, and emergency contact information for laboratory use of hydrofluoric acid.
Year:
2022
Region / City:
Not specified
Topic:
Hydrofluoric acid spill response
Document Type:
Instructional guide
Organization / Institution:
Office of Environmental Health & Safety (OEHS)
Author:
Not specified
Target Audience:
Laboratory personnel
Effective Date:
10/12/2022
Date of Changes:
Not specified
Expiration Date:
Two months before noted date on neutralizer bottle
Department:
Choose a department
Principal Investigator:
PI name
Group Safety Coordinator/Lab Manager:
Name of safety contact
SOP written by:
CoE SOP Committee
Date of this version:
Not specified
Date approved by PI/Lab Supervisor:
Not specified
Type of SOP:
Hazardous material
Chemical Substances Covered:
Hydrofluoric acid (HF), Buffered Oxide Etch (BOE), ammonium fluoride, sodium fluoride, ammonium hydrogen difluoride
Hazard Classification:
Corrosive, highly toxic
Intended Use:
Research laboratories
Required Approval:
Principal Investigator
Required Training:
Hands-on laboratory safety training
Required Equipment:
Chemical fume hood, emergency shower, eye wash, calcium gluconate kit
Storage Requirements:
Separate from bases and incompatible materials; not in glass containers
Document Sections:
Purpose, Key Points, Hazard Awareness, Emergency Response, Storage, Work Practices and Engineering Controls, PPE, Detailed Procedures, Waste Disposal, Training Record
Institutional Context:
Laboratory Safety Manual and Chemical Hygiene Plan
Note:
Year
Topic:
HIV Diagnosis, Linkage to Care, and Prevention Services
Document Type:
Guide
Organization / Institution:
CDC
Target Audience:
HIV-positive individuals who participated in the GAIN study
Note:
Year
Subject:
Chemical Safety, Laboratory Procedures
Document Type:
Standard Operating Procedure (SOP)
Target Audience:
Laboratory Personnel
Note:
Hazard Statements
Year:
2022
Region / City:
United States
Subject:
Environmental Protection, Lead Acid Battery Manufacturing
Document Type:
Regulatory Proposal
Organization / Institution:
Environmental Protection Agency (EPA)
Author:
Environmental Protection Agency
Target Audience:
Owners and operators of lead acid battery manufacturing plants
Period of Validity:
N/A
Approval Date:
February 2022
Date of Amendments:
February 27, 2014
Year:
2024
Region / city:
Australia
Topic:
Medical Research, Stroke, Cerebral Amyloid Angiopathy, Clinical Trial
Document Type:
Participant Information Sheet / Consent Form
Organization / institution:
Alfred Health
Author:
Dr. Oshi Swarup, Prof Geoffrey Cloud, Prof Nawaf Yassi
Target Audience:
Adults with Cerebral Amyloid Angiopathy
Period of Action:
26 weeks
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
N/A
Region / City:
N/A
Topic:
HIV Diagnosis, HIV Prevention
Document Type:
Survey
Organization / Institution:
CDC
Author:
N/A
Target Audience:
Participants of the GAIN Study
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2022
Region / city:
New South Wales, Australia
Theme:
Science, Chemistry
Document type:
Teaching Resource
Organization / Institution:
NSW Education Standards Authority
Author:
N/A
Target audience:
Teachers, students (Science Stage 5)
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Version:
HNY v2.0
Replaces version:
HNY v1.0
Clinical content last reviewed:
November 2023
Next review date:
April 2028
Note:
RDTC v1.0 8th March 2024
Local review and adoption:
September 2025
Approved for use by HNY ICB:
1st October 2025
Clinical content reviewed and updated by RDTC:
November 2023
Year:
2025
Region / City:
UK
Topic:
Healthcare, Medication Guidelines
Document Type:
Medical Protocol
Organisation:
National Ambulance Service Medical Directors (NASMeD)
Author:
Dr. Elizabeth Miller, Dr. Dave Macklin, Mr. Andy Curran, Rosie England, Cathryn James, Dan Haworth, Tracy Rogers, Jo Jenkins, Rosie Furner
Target Audience:
Registered healthcare professionals, Paramedics, Nurses, Midwives
Effective Date:
May 2023
Review Date:
October 2025
Expiry Date:
April 2026
Approval Date:
May 2025
Change History:
Includes updates to drug administration protocols and clinical guidelines
Note:
Year
Background:
The submission requested a General Schedule Authority Required (Telephone/Online) listing of a new form of adrenaline (epinephrine) acid tartrate 150 micrograms/0.15 mL autoinjector (AI) (Jext® Junior (Jr)) and 300 micrograms/0.3 mL AI (Jext®) under the same circumstances as the currently listed adrenaline (epinephrine) 150 microgram/0.3 mL AI (EpiPen® Jr and Anapen® Jr 150) and 300 microgram/0.3 mL AI (EpiPen® and Anapen® 300).
Year:
2019
Region / city:
Australia
Topic:
Medical device, eye care
Document type:
Public Summary Document
Organ / institution:
Therapeutic Goods Administration (TGA), Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Allergan Australia Pty Ltd
Target audience:
Healthcare professionals, medical practitioners
Period of validity:
Not specified
Approval date:
13 March 2019
Date of amendments:
Not specified
Year:
2026
Region / City:
Gainesville, FL
Topic:
Chemical Safety
Document Type:
Safety Procedure
Organization / Institution:
University of Florida
Author:
Environmental Health & Safety (EH&S)
Target Audience:
Laboratory Personnel
Effective Period:
Indefinite
Approval Date:
2026-02-07
Review Date:
Every 2 years
Revision Date:
N/A
Description:
A standard operating procedure detailing safety precautions, training requirements, and emergency contact information for laboratory use of hydrofluoric acid.
Year:
2023
Region / city:
Australia
Topic:
Chemical pollutants
Document type:
Technical report
Organization / institution:
Stockholm Convention
Author:
Unknown
Target audience:
Environmental scientists, regulators
Effective period:
Ongoing
Approval date:
Unknown
Date of amendments:
Unknown
Context:
A technical report on the environmental and health impacts of PFOA chemicals, detailing their historical use, regulatory status, and risks.
Note:
Year
Subject:
Biosafety, Recombinant Nucleic Acids, Synthetic Nucleic Acids, Biohazardous Materials
Document Type:
Registration Form
Institution:
Stanley Manne Children’s Research Institute, Ann & Robert H. Lurie Children’s Hospital of Chicago
Target Audience:
Researchers conducting experiments involving recombinant or synthetic nucleic acids or biohazardous materials
Year:
2023
Region / City:
International
Topic:
Nucleotide and amino acid sequence listings
Document type:
Standard
Organization / Institution:
SEQL Task Force
Audience:
Patent offices, applicants, and patent examiners
Period of validity:
Indefinite
Approval date:
Not provided
Date of amendments:
Not provided
Year:
2020
Region / City:
Florida
Topic:
Field Testing, Field Sampling, Environmental Monitoring
Document Type:
Standard Operating Procedures (SOP)
Organization / Institution:
Florida Department of Environmental Protection (FDEP)
Author:
Not specified
Target Audience:
Field technicians, environmental scientists, laboratories
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Changes:
2020